Top 10 Biotech Angel Investors in Italy in May 2025

Last updated: May 2025 A list of 10 angel investors that invest in Biotech startups based in Italy. We rank investors based on the number of investments they made in Biotech companies from Italy. We update this investor list every month.

Top 10 Biotech Angel Investors in Italy in May 2025

Investor	Biotech Italy investments
Stefano Bernardi	2
Stefano De Rossi	1
Michael Gebert	1
Giovanni Zobele	1
Hermann Hauser	1
Harald Oberrauch	1
Mauro Cogoli	1
Elena Paola Lanati	1
Enrico Pandian	1
Barbara Castellano	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Investment focus

Biotechnology, Software, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, Italy, France

Portfolio highlights

Freatic — Building the monetization layer for your alpha
CaSRevolution — A novel disease-modifying approach against neurodegeneration
Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.

Stefano De Rossi - Founder, CEO @ Leaning Technologies

Investment focus

Health Care, Biotechnology
Seed
Italy

Portfolio highlights

Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.

Michael Gebert - Chairman @ European Blockchain Association

Investment focus

Health Care, Biotechnology
Seed
Italy

Portfolio highlights

Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.

Giovanni Zobele

Investment focus

Health Care, Biotechnology
Seed
Italy

Portfolio highlights

Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.

Hermann Hauser is the Co-founder, Director, and Venture Partner of Amadeus Capital Partners. He previously worked at IXI as a Founder. Hermann Hauser attended the University of Vienna.

Investment focus

Software, Artificial Intelligence, Information Technology
Series A, Funding Round, Seed
United Kingdom, Austria, Italy

Portfolio highlights

Cogna — Cogna offers an AI-powered SaaS platform that streamlines the integration of data across several business domains.
NXRT — Driving simulations for sales and training
Fractile — Fractile is building chips to run large language models two orders of magnitude faster. Existing hardware is good for training LLMs, but very poorly suited to subsequent inference of the trained model, which is increasingly the dominant workload. A network’s weights need to be moved onto a chip once per word generated, and this movement takes a fewhundred times longer than the subsequent computations themselves. Fractile’s revolutionary approach to fusing computation with memory eliminates this bottleneck, and can scale to allow running the world’s largest models at a global scale.

Harald Oberrauch

Investment focus

Health Care, Biotechnology
Seed
Italy

Portfolio highlights

Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.

Mauro Cogoli

Investment focus

Health Care, Biotechnology
Seed
Italy

Portfolio highlights

Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.

Elena Paola Lanati

Investment focus

Biotechnology, Manufacturing, Nanotechnology
Seed
Italy

Portfolio highlights

Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.

Enrico Pandian is the Co-Founder and CEO of StartupGym and the Founder of FrescoFrigo. He previously worked at Checkout Technologies as a Co-Founder and President of the Board. Enrico Pandian attended the University of Verona.